Clinical Decision Support Tool for Treating Uncontrolled High Blood Pressure
Tests a clinic decision support tool to help lower blood pressure in adults.
Plain-language title generated from the registry record
Registry title: Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension
Key facts
- Where
- Cleveland, United StatesSee the site
Where in United States
- Cleveland ClinicCleveland, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Cleveland Clinic
- Trial code
- NCT07218198
- Record updated
- 7 October 2026
- Original description
The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension.Read full original descriptionShow less
A Stepped Wedged, Cluster Randomized Clinical Trial to Evaluate the Efficacy of a Clinical Decision Support Tool in the Treatment of Uncontrolled Hypertension
The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension.
Participants will:
Visit the clinic 4 weeks, after their initial clinician visit, for a BP check.
Inclusion: Men and women 18 years of age or older; Electronic Health Record (EHR) of hypertension AND prescribed at least one BP lowering medication; Office systolic BP of 130 mmHg or higher; Willing and able to comply with the study instructions AND attend a scheduled study visit.
Exclusion: In the opinion of the investigator, any other condition that will preclude participation in the study; Know heart failure with reduced ejection fraction and a left ventricular ejection fraction of less than 40%; End-stage kidney disease currently undergoing renal replacement therapy, or an eGFR < 15ml/min/1.73m2; Women who are pregnant, plan to become pregnant, or are breast-feeding.